Regulus Therapeutics Inc. said Pascale Witz was elected to the board at the company's June 1 annual stockholders meeting.
Most recently, she served as executive vice president, diabetes and cardiovascular, for Sanofi.
Regulus Therapeutics appoints director
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective
Regulus Therapeutics appoints director
- Author Tayyeba Irum
- Theme Healthcare & Pharmaceuticals
- Author
- Tayyeba Irum
- Theme
- Healthcare & Pharmaceuticals